Kojin Bio is a Japan-based biotechnology company engaged in the development, manufacturing, and sale of cell culture media, bacterial culture media, and in vitro diagnostic pharmaceuticals, as well as contract cell processing services. The company focuses particularly on serum-free media for regenerative medicine applications, including proprietary KBM-series products for immune cells (T cells, NK cells), mesenchymal stem cells, neural stem cells, and vascular endothelial cells. Its competitive strengths lie in specialized formulation expertise for cell therapy and biopharmaceutical manufacturing applications, with operations spanning Japan, Hong Kong, and China.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →Kojin Bio is a Japan-based biotechnology company engaged in the development, manufacturing, and sale of cell culture media, bacterial culture media, and in vitro diagnostic pharmaceuticals, as well as contract cell processing services. The company focuses particularly on serum-free media for regenerative medicine applications, including proprietary KBM-series products for immune cells (T cells, NK cells), mesenchymal stem cells, neural stem cells, and vascular endothelial cells. Its competitive strengths lie in specialized formulation expertise for cell therapy and biopharmaceutical manufacturing applications, with operations spanning Japan, Hong Kong, and China.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →